Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 330
Infectious Diseases Drugs 244
Vaccines 239
Animal Healthcare/Veterinary 193
Endocrine and Metabolic Disorders Drugs 174
Immune Disorders Drugs 152
Women's Health 136
Animal Pharmaceuticals 132
Central Nervous System Drugs 132
Cardiovascular Drugs 123
Pharmaceuticals 114
Drug Discovery 109
Musculoskeletal Disorders Drugs 105
Biopharmaceuticals 93
Respiratory Drugs 82
Clinical Trials 77
Oncology 74
Sexual and Reproductive Health Drugs 72
Allergy and Immunology 71
Liver and Kidney Disorders Drugs 69
Diabetes Drugs 67
Drug Delivery 61
Antibiotics 61
Biotechnology 60
Gastrointestinal Drugs 59
Enzymes 57
Genomics 52
Brain Cancer Drugs 43
Optical Disorders Drugs 42
Analgesics 42
Dermatological Drugs 42
Skin Cancer Drugs 38
Infusions and Injectables 37
Diagnostics 37
Pulmonary Medicine 35
Lymphoma Drugs 35
Cancer Vaccines 33
Biosimilars and Biosuperiors 33
Pharmaceutical Intermediates 32
Hematological Drugs 31
Urological Disorders Drugs 30
Lung Cancer Drugs 29
Pharmaceutical Manufacturing 29
Optical 27
HIV/AIDS Drugs 27
Liver Cancer Drugs 26
Over the Counter (OTC) Drugs 26
Healthcare Services 25
Prostate Cancer Drugs 24
Neurology 23
Infectious Disease Testing 23
Cervical Cancer Drugs 22
Allergy Drugs 22
Immunosuppressive Drugs 22
Breast Cancer Drugs 21
Leukemia Drugs 21
Cardiology 21
Mental Disorders Drugs 19
Psoriasis Drugs 19
Asthma Drugs 18
Colon Cancer Drugs 17
Bladder Cancer Drugs 17
Drugs by Therapeutic Area 16
Inhalers and Nebulisers 16
Dermatology 16
Vitamins and Dietary Supplements 16
Biomarkers 15
E-Healthcare 14
Fertility Services 14
Hematology 14
Pediatrics 14
Alzheimer's Disease Drugs 14
Ovarian Cancer Drugs 13
Medical Devices 13
Pancreatic Cancer Drugs 13
Gastroenterology 13
Urology and Nephrology 12
Nanomedicine 12
Anti-Obesity Drugs 12
Therapeutic Area 11
Generic Drugs 11
Kidney Cancer Drugs 11
In Vitro Diagnostics 10
Transdermal and Transmucosal Drug Delivery 10
Respiratory Devices 10
Thyroid Cancer Drugs 10
Anesthetic Drugs 8
Mental Health 8
Endocrinology 7
Bronchitis Drugs 7
Hepatology 6
Healthcare 6
Needles and Syringes 6
Uterine Cancer Drugs 6
Other Healthcare Facilities 6
Laboratory Equipment 6
Company Reports 5
Proteomics 5
Cough and Cold Drugs 4
Surgical Procedures 4
Molecular Diagnostics 4
Cardiovascular Devices 3
Diabetes Devices 3
Hospital Management 3
Acne Drugs 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Addiction Disorders Drugs 2
Patient Monitoring Equipment 2
Pharmacoeconomics 2
Laboratory Testing 2
Dental 2
Mammography 2
Blood Banking 2
Biomaterials 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Palliative Care 2
Maternal and Neonatal Care 2
Orthopedic Devices 1
Dialysis 1
Cholesterol Testing 1
Managed Care 1
Wound Care 1
Stem Cells 1
Neurology Devices 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

3,393 Results (Page 35 of 170)
- Relevance
  Sort by

Inactivated Polio and Rabies Vaccines - Global Strategic Business Report

 Report
November 2025
470 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Inactivated Vaccines - Global Strategic Business Report

 Report
November 2025
468 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Ebola Virus Vaccines - Global Strategic Business Report

 Report
November 2025
336 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Monkeypox Vaccine and Treatment - Global Strategic Business Report

 Report
November 2025
455 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Brucellosis Vaccines - Global Strategic Business Report

 Report
November 2025
276 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Combination Vaccines - Global Strategic Business Report

 Report
November 2025
373 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Hepatitis B Vaccines - Global Strategic Business Report

 Report
November 2025
182 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Tetanus Toxoid Vaccine - Global Strategic Business Report

 Report
November 2025
265 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Vaccine Market Size, Share & Trends Analysis Report By Type (Subunit, mRNA), By Route Of Administration (Oral), By Disease Indication (HPV, MMR), By Age Group (Adult), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

 Report
June 2025
180 Pages
Global

From

€5360EUR$5,950USD£4,729GBP

Loratadine - Global Strategic Business Report

 Report
November 2025
373 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Sulphonamides Market

 Report
January 2024
200 Pages
Global

From

€3738EUR$4,150USD£3,298GBP

Angioedema Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
81 Pages
Global

From

€3500EUR$4,162USD£3,196GBP

Conjugate Vaccines - Global Strategic Business Report

 Report
November 2025
271 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Shingles Vaccines - Global Strategic Business Report

 Report
November 2025
269 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Multivalent Vaccines - Global Strategic Business Report

 Report
November 2025
278 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Mumps Vaccines - Global Strategic Business Report

 Report
November 2025
288 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Chickenpox Vaccines - Global Strategic Business Report

 Report
November 2025
374 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Toxoid Vaccines - Global Strategic Business Report

 Report
November 2025
282 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Typhoid Fever Vaccines - Global Strategic Business Report

 Report
November 2025
372 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

Vaccine Technologies - Global Strategic Business Report

 Report
November 2025
573 Pages
Global

From

€5270EUR$5,850USD£4,650GBP

3,393 Results (Page 35 of 170)
- 1
- 33
- 34
- 35
- 36
- 37

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.